Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT

Br J Haematol. 2020 Jun;189(5):e213-e217. doi: 10.1111/bjh.16642. Epub 2020 Apr 16.
No abstract available

Keywords: allogeneic stem cell transplantation; multiple myeloma; myeloablative conditioning; reduced intensity conditioning; treosulfan.

Publication types

  • Comparative Study
  • Letter
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Busulfan / administration & dosage
  • Busulfan / adverse effects
  • Busulfan / analogs & derivatives*
  • Busulfan / therapeutic use
  • Disease-Free Survival
  • Drug Evaluation
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / mortality
  • Multiple Myeloma / therapy*
  • Myeloablative Agonists / administration & dosage
  • Myeloablative Agonists / adverse effects
  • Myeloablative Agonists / therapeutic use*
  • Proportional Hazards Models
  • Retrospective Studies
  • Transplantation Conditioning / methods*
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Treatment Outcome
  • Young Adult

Substances

  • Myeloablative Agonists
  • treosulfan
  • Busulfan